Assessment of the endothelial glycocalyx state in patients with axial spondyloarthritis associated with Crohn’s disease

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Epithelial barrier dysfunction, including their permeability increment, is supposed to be a pathogenetic link in the development of various immunoinflammatory diseases, including Crohn’s disease and axial spondyloarthritits. Endothelial permeability regulation is provided by both intercellular contacts and endothelial glycocalyx.

AIM: To study the microcirculatory state by measuring the endothelial glycocalyx thickness in patients with axial spondyloarthritits associated with Crohn’s disease. To identify an association between the endothelial glycocalyx thinning and the epithelial permeability severity in patients with Crohn’s disease, axial spondyloarthritits and their combination.

MATERIALS AND METHODS: 12 patients with axial spondyloarthritits associated with Crohn’s disease (group A), 22 patients with idiopathic axial spondyloarthritits (group B), 24 patients with Crohn’s disease (group C) and 16 healthy individuals (group D) were examined. The endothelial glycocalyx thickness was assessed in the sublingual region using dark-field microscopy. Fecal calprotectin and fecal zonulin was studied.

RESULTS: A statistically significant increase in the perfused boundary region high flow was found (p = 0.001), as well as the MicroVascular Health Score (p = 0.004) in group A compared with the control. In Group A, a positive correlation between perfused boundary region high flow and scores Ankylosing Spondylitis Disease Activity Score, Bath Ankylosing Spondylitis Disease Activity Index, Bath Ankylosing Spondylitis Metrology Index 10 (p < 0.05) was found; perfused boundary region 5–9 mµ correlated positively with the fecal calprotectin (p = 0.007). Perfused boundary region high flow measurement provides 77.1% accuracy for correct classification of axial spondyloarthritits associated with Crohn’s disease and idiopathic axial spondyloarthritits (p = 0.010). In group C, a positive correlation between fecal zonulin and perfused boundary region 5–9 mµ, 10–19 mµ, 5–25 mµ (p < 0.05) was also found.

CONCLUSIONS: The findings suggest that the patients with axial spondyloarthritits associated with Crohn’s disease have endothelial glycocalyx impairment; the detection of these abnormalities may be useful in assessing the disease integral activity and in the differential diagnosis of axial spondyloarthritits associated with Crohn’s disease and idiopathic axial spondyloarthritits. Further studies of microcirculation will allow better understanding of spondyloarthritis and inflammatory bowel diseases pathogenesis and improve the management of patients with these diseases.

Full Text

Restricted Access

About the authors

Denis A. Davydov

Academician I.P. Pavlov First St. Petersburg State Medical University

Author for correspondence.
Email: davydov.rheum@gmail.com
ORCID iD: 0000-0002-5524-1616
SPIN-code: 1132-5294
Scopus Author ID: 57217159189
ResearcherId: JWP-2975-2024

MD, postgraduate student

Russian Federation, 6/8 L’va Tolstogo St., Saint Petersburg, 197022

Valerii N. Marchenko

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: marchvn@mail.ru
ORCID iD: 0000-0002-2440-7222
SPIN-code: 1711-4150
Scopus Author ID: 57206419660

MD, Dr. Sci. (Med.), Professor

Russian Federation, 6/8 L’va Tolstogo St., Saint Petersburg, 197022

Daria A. Kuznetsova

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: lariwar@mail.ru
ORCID iD: 0000-0001-5318-354X
SPIN-code: 6110-6168
Scopus Author ID: 57205585994

MD, Cand. Sci. (Med.)

Russian Federation, 6/8 L’va Tolstogo St., Saint Petersburg, 197022

Zinaida L. Malakhova

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: zina_spb@mail.ru
ORCID iD: 0000-0003-2062-290X
SPIN-code: 1225-4143
Scopus Author ID: 56349857400

MD, Department of Ultrasound Diagnostics

Russian Federation, 6/8 L’va Tolstogo St., Saint Petersburg, 197022

Tatiana A. Lozovaya

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: lozota@inbox.ru
ORCID iD: 0009-0004-6589-5754
SPIN-code: 2592-8347

Cand. Sci. (Med.), MD, Functional Diagnostics Department №1

Russian Federation, 6/8 L’va Tolstogo St., Saint Petersburg, 197022

Artem A. Rubinstein

Academician I.P. Pavlov First St. Petersburg State Medical University; Institute of Experimental Medicine

Email: arrubin6@mail.ru
ORCID iD: 0000-0002-8493-5211
SPIN-code: 6025-1790
Scopus Author ID: 57417440100

ординатор

Russian Federation, 6/8 L’va Tolstogo St., Saint Petersburg, 197022; Saint Petersburg

Timur D. Vlasov

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: tvlasov@yandex.ru
ORCID iD: 0000-0002-6951-7599
SPIN-code: 8367-1246
Scopus Author ID: 7003323018
ResearcherId: C-6843-2014

MD, Dr. Sci. (Med.), Professor

Russian Federation, 6/8 L’va Tolstogo St., Saint Petersburg, 197022

References

  1. Clinical rheumatology. Guide for doctors. Ed. by V.I. Mazurov. 3rd ed. Moscow: E-noto, 2021. 696 p. (In Russ.)
  2. Kuzin AV, Rumiantsev VG. Arthritis associated with the inflammatory intestinal diseases. Russian Journal of Evidence-Based Gastroenterology. 2014;3(2):32–35. (In Russ.) EDN: SXTOUZ
  3. Di Jiang C, Raine T. IBD considerations in spondyloarthritis. Ther Adv Musculoskelet Dis. 2020;12:1759720X20939410. doi: 10.1177/1759720X20939410
  4. Benfaremo D, Luchetti MM, Gabrielli A. Biomarkers in inflammatory bowel disease-associated spondyloarthritis: State of the art and unmet needs. J Immunol Res. 2019;2019:8630871. doi: 10.1155/2019/8630871
  5. Widmer RJ, Lerman A. Endothelial dysfunction and cardiovascular disease. Glob Cardiol Sci Pract. 2014;2014(3):291–308. doi: 10.5339/gcsp.2014.43
  6. Marchenko VN, Shchukina OB, Davydov DA, et al. Endothelial dysfunction in axial spondyloarthritis associated with inflammatory bowel disease. Herald of North-Western State Medical University named after I.I. Mechnikov. 2022;14(4):17–32. (In Russ.) EDN: RPLPOO doi: 10.17816/mechnikov108408
  7. Vlasov TD, Lazovskaya OA, Shimanski DA, et al. The endothelial glycocalyx: research methods and prospects for their use in endothelial dysfunction assessment. Regional Blood Circulation and Microcirculation. 2020;19(1):5–16. (In Russ.) EDN: YVHFXQ doi: 10.24884/1682-6655-2020-19-1-5-16
  8. Chmielińska M, Olesińska M, Romanowska-Próchnicka K, Szukiewicz D. Haptoglobin and its related protein, zonulin-what is their role in spondyloarthropathy? J Clin Med. 2021;10(5):1131. doi: 10.3390/jcm10051131
  9. Simanenkov VI, Maev IV, Tkacheva ON, et al. Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus. Cardiovascular Therapy and Prevention. 2021;20(1):121–278. (In Russ.). doi: 10.15829/1728-8800-2021-2758
  10. Simanenkov VI, Maev IV, Tkacheva ON, et al. Epithelial protective therapy in comorbid diseases. practical guidelines for physicians. Terapevticheskii arkhiv. 2022;94(8):6–22. (In Russ.) EDN: KSTVKZ doi: 10.26442/00403660.2022.08.201523
  11. Szymanska E, Szymanska S, Dadalski M, Kierkus J. Biological markers of disease activity in inflammatory bowel diseases. Prz Gastroenterol. 2023;18(2):141–147. doi: 10.5114/pg.2023.129412
  12. Lam PK, McBride A, Le DHT, et al. Visual and biochemical evidence of glycocalyx disruption in human dengue infection, and association with plasma leakage severity. Front Med (Lausanne). 2020;7:545813. doi: 10.3389/fmed.2020.545813
  13. Rovas A, Sackarnd J, Rossaint J, et al. Identification of novel sublingual parameters to analyze and diagnose microvascular dysfunction in sepsis: the NOSTRADAMUS study. Crit Care. 2021;25(1):112. doi: 10.1186/s13054-021-03520-w
  14. Triantafyllou C, Nikolaou M, Ikonomidis I, et al. Effects of anti-inflammatory treatment and surgical intervention on endothelial glycocalyx, peripheral and coronary microcirculatory function and myocardial deformation in inflammatory bowel disease patients: a two-arms two-stage clinical trial. Diagnostics (Basel). 2021;11(6):993. doi: 10.3390/diagnostics11060993
  15. Malíčková K, Francová I, Lukáš M, et al. Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers. Pract Lab Med. 2017;9:39–44. doi: 10.1016/j.plabm.2017.09.001
  16. Caviglia GP, Dughera F, Ribaldone DG, et al. Serum zonulin in patients with inflammatory bowel disease: a pilot study. Minerva Med. 2019;110(2):95–100. doi: 10.23736/S0026-4806.18.05787-7
  17. Lacombe LAC, Matiollo C, Rosa JSD, et al. Factors associated with circulating zonulin in inflammatory bowel disease. Arq Gastroenterol. 2022;59(2):238–243. doi: 10.1590/S0004-2803.202202000-43

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Pic. 1. Schematic representation of the endothelial glycocalyx perfused boundary region (generated in biorender.com)

Download (154KB)
3. Fig. 2. Comparison of the value of the MicroVascular Health Score in the studied groups. Statistically significant difference: axial spindyloarthritis associated with Crohn’s disease vs axial spondyloarthritis (p = 0,010) and control (p = 0,004). axSpA — axial spondyloarthritis; CD — Crohn’s disease; CD-axSpA — axial spindyloarthritis associated with Crohn’s disease

Download (75KB)
4. Fig. 3. Evaluation of the prognostic significance of the perfused boundary region high flow in the differential diagnosis between idiopathic axial spondyloarthritis and axial spondyloarthritis associated with Crohn’s disease

Download (166KB)
5. Fig. 4. Evaluation of the effect of systemic glucocorticoid therapy on the glycocalyx parameters of microcirculatory vessels of various diameters in the patients with Crohn’s disease

Download (123KB)
6. Fig. 5. Scatter diagram of the correlation of articular activity with Perfused Boundary Region in CD-axSpA and idiopathic axSpA. axSpA — axial spondyloarthritis, CD-axSpA — axial spondyloarthritis associated with Crohn’s diseasers in the patients with Crohn’s disease

Download (164KB)

Copyright (c) 2024 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 71733 от 08.12.2017.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies